Iamin-IB: Began Phase I/II trial dose-ranging trial of safety and efficacy in 50 patients with mild or moderate disease

ProCyte Corp. (PRCY), Kirkland,

Read the full 44 word article

How to gain access

Continue reading with a
two-week free trial.